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Abstract
Background:  The molecular events underlying mammary development during pregnancy,
lactation, and involution are incompletely understood.
Results: Mammary gland microarray data, cellular localization data, protein-protein interactions,
and literature-mined genes were integrated and analyzed using statistics, principal component
analysis, gene ontology analysis, pathway analysis, and network analysis to identify global biological
principles that govern molecular events during pregnancy, lactation, and involution.
Conclusion: Several key principles were derived: (1) nearly a third of the transcriptome fluctuates
to build, run, and disassemble the lactation apparatus; (2) genes encoding the secretory machinery
are transcribed prior to lactation; (3) the diversity of the endogenous portion of the milk proteome
is derived from fewer than 100 transcripts; (4) while some genes are differentially transcribed near
the onset of lactation, the lactation switch is primarily post-transcriptionally mediated; (5) the
secretion of materials during lactation occurs not by up-regulation of novel genomic functions, but
by widespread transcriptional suppression of functions such as protein degradation and cell-
environment communication; (6) the involution switch is primarily transcriptionally mediated; and
(7) during early involution, the transcriptional state is partially reverted to the pre-lactation state.
A new hypothesis for secretory diminution is suggested – milk production gradually declines
because the secretory machinery is not transcriptionally replenished. A comprehensive network of
protein interactions during lactation is assembled and new regulatory gene targets are identified.
Less than one fifth of the transcriptionally regulated nodes in this lactation network have been
previously explored in the context of lactation. Implications for future research in mammary and
cancer biology are discussed.
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Background
Lactation is one of the most remarkable products of evo-
lution. The signature feature and basis of the competitive
emergence of mammals, including humans, is the pro-
duction of complete early nourishment of neonates by the
mother. The processes of lactation include the develop-
ment of mammary tissue, as well as the synthesis and
secretion of milk. At weaning, the mammary gland mor-
phologically returns to a near pre-pregnant state. Thus, in
addition to the important nutritional implications, lacta-
tion provides a model for basic biological processes such
as the proliferation, differentiation, survival and death of
cells.
Although lactation is believed to be a product of Darwin-
ian selective pressure, little is known of its molecular ori-
gins or its regulation. Current knowledge of the molecular
regulation of mammary development and lactation has
largely been derived from dissection of signaling networks
in cell culture systems and phenotypic characterization of
genetically altered mice. Some proteins modulated during
pregnancy and lactation have been identified and charac-
terized in the context of hormonal and metabolic path-
ways (reviewed in [1,2]). Beyond these signaling
pathways, the regulation of mammary gland development
and lactation is incompletely understood. Of particular
interest are the major molecular events that govern mac-
roscopic and histological changes in the mammary gland
during secretory differentiation, secretory activation (the
lactation switch), and the onset of involution (the involu-
tion switch). Unbiased genome-wide approaches are
likely to identify novel genes and gene products involved
in the regulation of lactation, particularly when incorpo-
rated into a larger picture of mammary development and
function.
In this study, bioinformatic techniques are applied to
transcriptomic and proteomic data to enhance under-
standing of how the mammary gland is regulated through
pregnancy, lactation, and involution. Using non-hypoth-
esis-driven analyses, transcriptional and post-transcrip-
tional trends are described and putative key regulatory
targets are identified. Gene products and their interactions
unexplored in the current literature are visualized as a net-
work, providing a framework on which to base future
research. Such exploratory methods can be applied to
other areas of biological inquiry to establish a quantitative
representation of current knowledge and to facilitate the
generation of new hypotheses.
Results
Global transcriptional trends during mammary 
development
Using microarray data from the Neville study [3] (see
Methods), a statistical analysis of genome-wide transcrip-
tional changes in the mammary gland was applied to
identify 4,832 genes differentially expressed (p < 0.001) of
the 12,488 measured during a full mouse lactation cycle.
To understand the major trends in gene transcription
across developmental stages of the mammary gland from
initial pregnancy to involution, a principal component
analysis with mean centering and scaling was applied to
these differentially expressed genes across all ten time
points. (For descriptions of these time points, see Materi-
als and methods.) The top three principal components of
the data in the time domain are diagrammed in Figures
1A–C. The first principal component describes 50.0% of
the variance in the data. This major trend is a rise in gene
expression during late pregnancy that remains high dur-
ing lactation and falls during involution. A substantial set
of genes – 592 – has a standard correlation of 0.90 or bet-
ter with this first principal component (Additional data
file 1). The second and third principal components appear
to be minor trends, explaining 13.6 and 11.6% of the var-
iance in the data. In the second principal component (Fig-
ure 1B), expression is unchanged during pregnancy and
lactation, but rises during involution. In the third princi-
pal component (Figure 1C), gene expression rises in late
pregnancy, is depressed during lactation, and then rises
again during involution. Few genes, twelve and three,
respectively, have a standard (uncentered) correlation of
0.90 or better with the second and third principal compo-
nents. Each of the remaining principal components
explains less than 10% of the variance in the data.
Because few genes are strongly correlated with the second
and third principal components, other gene lists associ-
ated with these trends may be of greater biological inter-
est. For the second component, the 2,064 genes that are
statistically up-regulated during involution day 2 (I2)
compared to lactation day 9 (L9) are provided as part of
Additional data file 5. With respect to the third principal
component, the 634 genes that are down-regulated by lac-
tation day 2 (L2) relative to pregnancy day 17 (P17) and
up-regulated by I2 relative to L9 are provided in Addi-
tional data file 2.
How do these principal components in Figure 1 relate to
the known histology (reviewed in [4,5]) of the mouse
mammary gland? In the first part of pregnancy, the epithe-
lial compartment of the gland undergoes a remarkable
expansion, from less than 10% of the total volume to
about 90% by birth. This proliferative activity is greatest
prior to time point pregnancy day 12 (P12). The rise
between pregnancy day 1 (P1) and P12 in the third prin-
cipal component may reflect an increase in expression of
epithelial genes due to the increase in this cell population.
Secretory differentiation, characterized by an increase in
lipid droplets in the cells, begins about mid-pregnancy
and continues through P17, at which point the dropletsBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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mostly fill the alveolar cells until parturition, pregnancy
day 19 (P19), when the lipid droplets move into the
lumen representing the first onset of milk secretion.
Approximately half of the variance in the microarray data
can be described by the first principal component (see Fig-
ure 1A) in which gene expression increases from P12 to
P19. This suggests that the transcriptional changes neces-
sary to prepare the gland for secretion during this time
period are the strongest trend across the entire develop-
mental cycle. Soon after parturition, P19, the lipid drop-
lets disappear from the lumen as milk is removed by the
suckling offspring and the gland begins copious milk pro-
duction. Lactation reaches full maturation by about lacta-
tion day 7 and certainly by time point L9. The third
principal component implies that the transcription of a
subset of genes may be suppressed during lactation.
At weaning, the mammary gland returns to the pre-preg-
nant state within four to ten days [6]. In the microarray
study, the I2 time point may be interpreted as early invo-
lution because it occurred two days after the pups were
removed. The second principal component shows a sharp
upward trend in gene expression between L9 and I2. Very
few genes are strongly correlated with this principal com-
ponent, despite the fact that over 2,000 genes are statisti-
cally up-regulated between L9 and I2. This suggests that
these genes that are markedly induced during involution
are not coordinately regulated during pregnancy or lacta-
tion. In other words, involution represents a totally new
phase of mammary development that follows a pathway
distinct from the pathways that lead to milk secretion.
To investigate the biological functions represented by the
first principal component, gene ontology (GO) analysis
was applied to the 592 genes with a standard correlation
of 0.90 or better with the component's profile (Additional
data file 1). Non-synonymous enriched GO terms that
describe the annotated biological processes represented
by these genes are listed in Table 1 in statistically ranked
order. Some of the annotated functions associated with
this profile are consistent with known functions of mam-
mary epithelial cells (MECs) during lactation – ion trans-
port, calcium-mediated signaling, transferase activity, and
cell proliferation. It is interesting that genes associated
with these known functions appear to be transcribed well
in advance of the onset of lactation. The remaining GO
terms in Table 1 suggest that some genes that have been
annotated with respect to immune cells are important to
the development of the mammary gland during late preg-
nancy.
The genes correlated with the first principal component
were also analyzed for enrichment in metabolic and sign-
aling pathways. None of the 152 canonical pathways were
statistically significant (p < 0.05) or even marginally sig-
nificant (unadjusted p < 0.05). It is likely that these genes
Table 1: First principal component, significant biological 
processes
GOID GO Term
45410 Positive regulation of interleukin-6 biosynthesis
50850 Positive regulation of calcium-mediated signaling
42108 Positive regulation of cytokine biosynthesis
50671 Positive regulation of lymphocyte proliferation
51347 Positive regulation of transferase activity
30001 Metal ion transport
The major trend is a gradual increase in gene expression  from mid to late pregnancy Figure 1
The major trend is a gradual increase in gene expres-
sion from mid to late pregnancy. The (A) first, (B) sec-
ond, and (C) third principal components of genome-wide 
gene expression data from early pregnancy through involu-
tion explain (A) 50.0%, (B) 13.6%, and (C) 11.6% of the vari-
ance, respectively.
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that are coordinately regulated during mammary develop-
ment participate in pathways that are not yet annotated.
Pairwise comparisons between developmental stages were
examined to find other underlying trends in the data. The
number of genes whose expression differs significantly
from the previous time point is plotted in Figure 2A.
Clearly, the transcriptional changes are very gradual across
pregnancy until involution, suggesting that there is no
sudden transcriptional switch at the time of parturition.
However, there does appear to be a massive transcrip-
tional change between full lactation and involution.
To assess cumulative transcriptional changes over the full
lactation cycle, the number of genes whose expression dif-
fers significantly (p < 0.001) from the first time point, P1,
is plotted in Figure 2B. The late pregnancy transcriptional
state is quite divergent from the initial pregnancy state
and the greatest extent of divergence has occurred by full
lactation. This graph hints at the possibility of a conver-
gence to the pre-lactation state at the time of early involu-
tion, but it does not directly test the number of genes
different between the late pregnancy time points and
involution. The number of genes whose expression differs
significantly (p < 0.001) from the involution time point,
I2, is plotted in Figure 2C. The time point with the closest
transcriptional state to I2 is the late pregnancy time point,
P17. Of the 2,468 genes with statistically different expres-
sion in the transition from L9 to I2 (Figure 2A), the
expression of 1,688 of these genes is not different between
P17 and I2. In other words, 68% of the transcriptional
changes between L9 and I2 can be attributed to a partial
return to the pre-lactation state. Conceptually, the MECs
may be exploring new frontiers of the transcriptional state
space to satisfy the unusual requirements of lactation,
frontiers from which they must retreat before they can
proceed with the involution program.
Transcriptionally regulated biological functions during 
mammary development
Functions of genes clustered by transcriptional profiles
during mammary development have been previously
described [3,7,8]. Here, GO analysis is used to screen for
additional unexpected transcriptionally regulated biolog-
ical functions and trends during pregnancy, lactation, and
involution (Tables 2, 3, and 4, respectively). To facilitate
future study, lists of genes associated with the GO terms in
Tables 2, 3, 4 are provided (Additional data files 7, 8, 9).
Pregnancy Gene Set: early pregnancy (P1) to parturition (P19)
By the end of pregnancy, P19, 985 genes are up-regulated
and 1,265 genes are down-regulated relative to the start of
pregnancy, P1. To screen for transcriptionally modulated
biological functions during pregnancy, this Pregnancy
Gene Set (see Methods) was analyzed for enriched GO
terms. Statistically significant biological process GO terms
associated with genes up-regulated during pregnancy are
listed in Table 2. Biological processes associated with
Genome-wide transcriptional changes occur at the involution  switch, but not at the lactation switch Figure 2
Genome-wide transcriptional changes occur at the 
involution switch, but not at the lactation switch. (A) 
Each data point represents the number of genes that are dif-
ferentially transcribed relative to the previous time point. 
Five times as many transcriptional changes occur between full 
lactation, L9, and involution, I2, compared to any other tran-
sition between time points. (B) Each data point represents 
the number of genes that are differentially transcribed at that 
reproductive stage relative to early pregnancy, time point P1. 
These transcriptional changes suggest a gradual divergence 
from early pregnancy that increases until full lactation, L9, 
with a possible convergence to the pre-lactation state at 
involution. (C) Each data point represents the number of 
genes that are differentially transcribed at that time point rel-
ative to early involution, time point I2. The closest transcrip-
tional state to I2 is P17. Of the 2,468 genes with statistically 
different expression in the transition from L9 to I2, 1,688 of 
these genes are not different between P17 and I2. Therefore, 
the involution switch is characterized by a partial reversion 
to the pre-lactation transcriptional state.
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genes up-regulated during this period are dominated by
the synthesis, transport, localization, and secretion of pro-
teins and by transport of ions. MECs appear to be
involved in a massive operation of synthesizing and pack-
aging materials before the onset of lactation. Eight of the
nine enriched GO terms are related to protein transport,
localization, and secretion. This analysis suggests that
many of the genes for milk synthesis and secretion are
transcribed prior to the onset of lactation.
One of the nutritional properties of milk is the co-delivery
of mineral ions in excess of their normal poor bioavaila-
bility in aqueous matrices, implying that the processes of
lactation must include substantial ion transport capabili-
ties. GO analysis (Table 2) implies that the increased tran-
scription of genes associated with ion transport begins
during pregnancy. With respect to ion transport, both zinc
and iron ion transport systems are up-regulated. However,
some genes associated with iron transport are also down-
regulated. Ceruloplasmin (Cp, [GenBank:U49430]), ferritin
heavy chain 1 (Fth1, [GenBank:X52561]), lactotransferrin
(Ltf, [GenBank:J03298]),  sideroflexin 2 (Sfxn2, [Gen-
Bank:AA189555]), and transferrin receptor (Tfrc, [Gen-
Bank:X57349]) are up-regulated, while ferritin light chain
1  (Ftl1, [GenBank:L39879]),  hephaestin  (Heph, [Gen-
Bank:AF082567]),  hemochromatosis  (Hfe, [Gen-
Bank:Y12650]),  sideroflexin 1 (Sfxn1,
[GenBank:NM_027324]), and solute carrier family 11 mem-
ber 1 (Slc11a1, [GenBank:L13732]) are down-regulated.
As zinc, copper, and iron are preferentially channeled
through the MECs into the milk [9], this transcriptional
modulation of ion transport systems probably reflects this
process.
Table 3: Lactation Gene Set, significant biological processes
GO ID GO Term
DOWNREGULATED
46907 Intracellular transport
6886 Intracellular protein transport
9059 Macromolecule biosynthesis
6412 Protein biosynthesis
51649 Establishment of cellular localization
15031 Protein transport
6635 Fatty acid beta-oxidation
51641 Cellular localization
19538 Protein metabolism
6878 Copper ion homeostasis
16043 Cell organization and biogenesis
6512 Ubiquitin cycle
45184 Establishment of protein localization
8104 Protein localization
245 Spliceosome assembly
398 Nuclear mRNA splicing, via spliceosome
377 RNA splicing, via transesterification reactions with bulged 
adenosine as nucleophile
375 RNA splicing, via transesterification reactions
30163 Protein catabolism
8380 RNA splicing
43632 Modification-dependent macromolecule catabolism
19941 Modification-dependent protein catabolism
43170 Macromolecule metabolism
19395 Fatty acid oxidation
44249 Cellular biosynthesis
6511 Ubiquitin-dependent protein catabolism
44267 Cellular protein metabolism
44260 Cellular macromolecule metabolism
44257 Cellular protein catabolism
51603 Proteolysis during cellular protein catabolism
16071 mRNA metabolism
9058 Biosynthesis
51170 Nuclear import
17038 Protein import
43285 Biopolymer catabolism
19883 Antigen presentation, endogenous antigen
30036 Actin cytoskeleton organization and biogenesis
51169 Nuclear transport
30333 Antigen processing
6913 Nucleocytoplasmic transport
6397 mRNA processing
6606 Protein import into nucleus
43037 Translation
6413 Translational initiation
6605 Protein targeting
7010 Cytoskeleton organization and biogenesis
Table 2: Pregnancy Gene Set, significant biological processes
GO ID GO Term
UPREGULATED
48193 Golgi vesicle transport
45045 Secretory pathway
41 Transition metal ion transport
45047 Protein targeting to ER
46903 Secretion
6888 ER to Golgi vesicle-mediated transport
6810 Transport
51179 Localization
51234 Establishment of localization
DOWNREGULATED
6817 Phosphate transport
15698 Inorganic anion transport
6820 Anion transport
6635 Fatty acid beta-oxidation
19395 Fatty acid oxidation
6631 Fatty acid metabolism
1944 Vasculature development
48514 Blood vessel morphogenesis
1568 Blood vessel development
7155 Cell adhesion
6082 Organic acid metabolism
19752 Carboxylic acid metabolism
9653 MorphogenesisBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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Table 2 also lists statistically significant biological process
GO terms associated with genes down-regulated during
pregnancy. These GO terms point to three major functions
– anion transport, fatty acid oxidation, and blood vessel
development. 'Phosphate transport' is the most highly
enriched GO term associated with genes down-regulated
by late pregnancy. Genes annotated with this GO term are
almost all pro-collagen genes, and it is this collagen-form-
ing function that more accurately describes genes up-reg-
ulated during pregnancy than 'phosphate transport'. The
'phosphate transport' annotation appears to be out of
context when applied to the mammary gland. It was pre-
viously suggested that down-regulation of collagen genes
is either due to a reduction of the stromal compartment or
the expansion of the epithelial compartment in the mam-
mary gland [3]. Table 2 also lists 'fatty oxidation'. It is
expected that oxidation of fatty acids would be down-reg-
ulated during lactation, and these results show that, con-
sistent with prior study [3], this function is already down-
regulated by late pregnancy.
Surprisingly, genes usually associated with vasculature
development appear to be down-regulated, a finding that
is not consistent with what is known to be true at the mac-
roscopic level. The gland experiences significant angio-
genesis during pregnancy as this process is a necessary
prerequisite for lactation. In the rat, the vasculature dou-
bles by mid-pregnancy through angiogenesis by sprouting
and intersucception [10]. The 'angiogenesis' GO annota-
tions are likely dictated by cancer research, so there may
be genes in the genetic circuit controlling vascularization
of normal mammary development that are not yet anno-
tated as such. To facilitate further study, genes associated
with these GO terms are provided in Additional files 2, 3,
4. Although some of the biological functions listed in
Table 2 are expected given prior study [3], screening with
GO terms indicates the following: some GO terms may
generally be out of context when applied to the mammary
gland, elements of the secretory pathway are up-regulated
prior to parturition, and the vascularization of the normal
mammary gland may be incompletely understood at the
level of transcription.
Lactation Gene Set: parturition (P19) to mature lactation (L9)
Relative to parturition (P19), 122 genes are up-regulated
and 1,704 are down-regulated by the time of mature lac-
tation, L9. This Lactation Gene Set (see Methods) was ana-
lyzed for enriched GO terms. Surprisingly, no GO terms
are statistically enriched among genes up-regulated during
this time period. This leads one to question whether genes
up-regulated during lactation are not annotated. How-
ever, both up-regulated and down-regulated probes are
annotated to approximately the same level, 87 and 89%,
respectively. It is possible that the gene set is too small to
find statistically enriched terms, or that the genes up-reg-
ulated during lactation have disparate functions, or that
the common functions have not yet been annotated for
their lactation-specific functions.
Enriched GO terms associated with genes down-regulated
during lactation relative to parturition are given in Table
3. As during pregnancy, beta-oxidation of fatty acids is
suppressed. Because one of the major functions of the
mammary gland during lactation is the synthesis and
packaging of lipids, it would be expected that oxidative
consumption of such lipids for energy by the same cells
would be counterproductive. Surprisingly, the transcrip-
tion of genes involved in protein transport is suppressed
during lactation. Thus, the main functions of packaging
and exporting proteins by the traditional secretory path-
way during the latter part of pregnancy may be transcrip-
tionally attenuated during lactation. As shown in Table 3,
'protein metabolism' – both biosynthesis and catabolism
Table 4: Involution Gene Set, significant biological processes
GO ID GO Term
UPREGULATED
6512 Ubiquitin cycle
16043 Cell organization and biogenesis
46907 Intracellular transport
51649 Establishment of cellular localization
51641 Cellular localization
43632 Modification-dependent macromolecule catabolism
19941 Modification-dependent protein catabolism
6886 Intracellular protein transport
15031 Protein transport
6878 Copper ion homeostasis
6511 Ubiquitin-dependent protein catabolism
8104 protein localization
45184 Establishment of protein localization
30163 Protein catabolism
16192 Vesicle-mediated transport
43285 Biopolymer catabolism
15992 Proton transport
6979 Response to oxidative stress
245 Spliceosome assembly
19538 Protein metabolism
DOWNREGULATED
48009 Insulin-like growth factor receptor signaling pathway
7595 Lactation
9309 Amine biosynthesis
44271 Nitrogen compound biosynthesis
8652 Amino acid biosynthesis
6220 Pyrimidine nucleotide metabolism
6084 Acetyl-CoA metabolism
44237 Cellular metabolism
8152 Metabolism
9058 Biosynthesis
44249 Cellular biosynthesis
9117 Nucleotide metabolismBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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– has also been transcriptionally turned down during lac-
tation. In particular, ubiquitin-dependent protein catabo-
lism is suppressed. Likewise, genes annotated for
'spliceosome assembly' – a ribonucleoprotein apparatus
that catalyzes nuclear mRNA splicing – are also down-reg-
ulated, implying that both mRNA and protein processing
are essentially halted or dramatically slowed during lacta-
tion. However, synthesis of the major milk proteins is
known to be highly up-regulated [3]. Thus, it is likely that
a small subset of genes is specifically utilized by the lactat-
ing gland to process proteins for secretion.
Genes associated with 'antigen processing' or 'antigen
presentation' are also statistically down-regulated during
lactation relative to late pregnancy. Although the com-
plete immune function of colostrum may not be known,
it is well-accepted that colostrum, which would be
expected to be functionally tied to the genes transcribed in
late pregnancy, has substantial immune components. Per-
haps these genes, or a subset of them, are unique to colos-
trum and thus, their transcription is switched off by the
time of full lactation. In summary, the lactation period
appears to be characterized by widespread suppression of
transcription across many functional classes.
Involution Gene Set: mature lactation (L9) to involution (I2)
By involution, time point I2, 2,064 genes are up-regulated
and 404 genes are down-regulated relative to mature lac-
tation, L9. GO analysis of this Involution Gene Set (see
Methods) yields enriched GO terms for both up-regulated
and down-regulated genes (Table 4). Seventeen of the
twenty enriched GO terms (85%) associated with up-reg-
ulation during involution exactly match GO terms of the
genes down-regulated during lactation. Transcriptionally,
the switch to involution largely reverses the state of lacta-
tion. Genes involved in protein transport are transcribed
again, re-enabling the traditional secretory pathway, for
example. Protein catabolism is up-regulated, an expected
major function during involution of the mammary gland.
The 'response to oxidative stress' GO term is probably
associated with the massive protein catabolism that is tak-
ing place, either to protect the MECs or the surrounding
cells. Genes involved in metal ion homeostasis, especially
copper, are also transcribed again.
Proton transport is up-regulated during involution.
Because both ATP synthesis-coupled and ATP hydrolysis-
coupled proton transport are up-regulated, the up-regula-
tion of these genes is probably not reflective of an ener-
getic transition of the mammary cells. It is possible that
this set of genes is up-regulated to facilitate the degrada-
tion of milk components and the transfer of the small
molecules to the interstitial compartment.
Far fewer genes, only 404, are down-regulated during
involution. Nevertheless, a few clustered biological func-
tions are represented (Table 4). In general, biosynthetic
and metabolic processes are down-regulated, as would be
expected of involuting cells. Overall, early involution
appears to be characterized by a suppression of specific
lactation functions and up-regulation of genes associated
with novel functional categories.
Transcriptionally regulated pathways during mammary 
development
To identify which of the known metabolic and signaling
pathways are transcriptionally regulated, pathway analy-
sis was applied to the Pregnancy, Lactation, and Involu-
tion Gene Sets (see Methods). Of the 152 canonical
pathways evaluated, 16 are marginally significant during
pregnancy, 22 during lactation, and 40 during involution
(unadjusted p < 0.05). When a multiple testing correction
is applied (see Methods), no pathways are significant dur-
ing pregnancy, 8 are significant during lactation, and 24
are significant during involution (p < 0.05). The complete
list of pathways, their p-values, and the molecules regu-
lated in those pathways are provided (Additional data file
19), as well as color-coded diagrams for the significant
pathways (Additional data file 20, 21, 22). An interpreta-
tion of all of these pathways is well beyond the scope of
this paper. Therefore, the three pathways that most signif-
icant during lactation are briefly explored in the following
sections.
PI3K-AKT pathway
In this pathway analysis, the PI3K-AKT pathway (Figure 3)
is the most significant transcriptionally regulated pathway
during pregnancy. At the center of Figure 3A, the AKT
node is a mixture of red and green because the members
that comprise this node are differentially regulated. Akt1
[GenBank:X65687] is up-regulated, Akt2 [Gen-
Bank:U22445] is down-regulated, and calmodulin, which
complexes with Akt2, is down-regulated. During early
involution (Figure 3C): Akt1 is down-regulated while
Akt2 is up-regulated. Studies with transgenic and knock-
out mice illustrate differential physiological roles and tis-
sue-specific functions for the two Akt isoforms [11]. It is
possible that the differential regulation throughout the
pathway seen during pregnancy (Figure 3A) is due to the
heterogeneous cell populations of the mammary gland
with Akt2 regulated in adipose tissue and Akt1 is regulated
in epithelial cells. However, the two isoforms are recipro-
cally modulated during early involution when the epithe-
lial cells are the predominant cell type, so it is also
possible that the isoforms are co-regulated in the same tis-
sue.
The PI3K-AKT pathway is highly significant during lacta-
tion (p = 0.0101) and involution (p < 0.0001) (Figure 3B–BMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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The PI3K-AKT pathway is transcriptionally regulated throughout the lactation cycle Figure 3
The PI3K-AKT pathway is transcriptionally regulated throughout the lactation cycle. The PI3K-AKT pathway is 
enriched with genes differentially regulated during (A) pregnancy, (B) lactation, and (C) involution. Green nodes are down-reg-
ulated, red nodes are up-regulated.
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C). Thus, the pathway analysis suggests that Akt is a cen-
tral regulator throughout the lactation cycle. Also, Akt1
appears to be the sole down-regulated protein in the path-
way during involution, implying a critical regulatory role
during this developmental stage. Experimental data sup-
ports these findings. Akt expression increases dramatically
at the onset of lactation but is relatively low during invo-
lution [12]. In transgenic mice with constitutively active
Akt1, involution is delayed, suggesting that Akt1 is an
essential regulator of involution [13-15]. Interestingly, the
overexpression of Akt1 in these mice during the preg-
nancy and lactation stages pathologically enhanced lipo-
genesis [12]. The fat content of the milk was 65–70%,
compared to 25–30% in wild-type mice. Thus, experi-
mental evidence supports Akt1 as a central regulator dur-
ing all phases of lactation. In Figure 3, genes that are
transcribed to form products upstream and downstream
of Akt1 are also significantly transcriptionally regulated.
The enrichment of the entire PI3K-AKT pathway for differ-
entially regulated genes in the three time periods analyzed
in this paper suggests that the entire pathway, and not
solely Akt1, is coordinately regulated throughout the lac-
tation cycle.
Integrin pathway
Integrins are cell-surface receptors that attach the cell to
the surrounding extra-cellular matrix and transduce sig-
nals from the matrix to the cell. Through integrins, the
extra-cellular matrix influences the growth, differentia-
tion, and survival of mammary epithelial cells [16]. In this
analysis, the integrin pathway (Figure 4) is marginally sig-
nificantly enriched for transcriptionally regulated genes
during pregnancy (unadjusted p = 0.0063) and signifi-
cantly enriched during lactation (p < 0.0001), and involu-
tion (p < 0.0001). During pregnancy, the two major tissue
types of the mammary gland change dramatically: the adi-
pose compartment shrinks while the epithelial cell com-
partment differentiates and proliferates. Thus, the
pathway diagram in Figure 4A with both up- and down-
regulated regulation of both the integrins and their down-
stream components is unsurprising given the opposite
developmental programs of the heterogeneous cell popu-
lations. During lactation, the regulation of the integrin
pathway (Figure 4B) illustrates down-regulation of the
downstream components of integrins. In other words, sig-
nals coming from the extra-cellular matrix to the mam-
mary epithelial cells are attenuated. This reflects a major
change in integrin signaling and further implies that the
primary function of MECs during lactation – milk synthe-
sis – does not require much communication with sur-
rounding environment. During early involution (Figure
4C), the downstream components of the integrin path-
ways are again up-regulated, perhaps reflecting a need for
increased cell-environment communication to coordinate
the complex tissue remodeling that characterizes this time
period. However, the diagrams in Figure 4 may incom-
pletely describe the status of the integrin pathway due to
post-transcriptional regulation. Western blots of beta-
integrins during early involution demonstrate a decrease
in this protein [17], not the increase that is forecasted
based on microarray data in Figure 4C. Nevertheless, sig-
nificant enrichment of this pathway with transcriptionally
regulated genes makes a strong argument for intense reg-
ulation of the integrin pathway throughout the lactation
cycle.
Protein ubiquitination pathway
The protein ubiquitination pathway (Figure 5) is not sig-
nificantly enriched for transcriptionally regulated genes
during pregnancy. However, it is the most significantly
enriched pathway during both lactation and involution (p
< 0.0001). The degradation of cell cycle regulators by
ubiquitination is an essential part of normal cell cycle
control and thus it has been studied in the mammary
gland in the context of breast cancer. However, its signifi-
cance in normal mammary biology is less obvious. A
decline in proteosomal proteins in the mammary gland
during lactation has been previously noted [3]. Here, the
pathway diagram in Figure 5B demonstrates that the sup-
pression of the protein ubiquitination pathway is nearly
unanimous. Then, during involution, most of the same
nodes are again up-regulated (Figure 5C). These results
imply that mammary epithelial cells, in their highly spe-
cialized state during lactation, require complete suppres-
sion of ubiquitin-directed protein degradation.
Furthermore, in terms of the total number of genes regu-
lated within a pathway, the highest priority during early
involution is to re-enable the degradation of proteins. In
summary, modulation of the protein ubiquitination path-
way is perhaps the most important innovation of lactating
mammary epithelial cells.
Biological principles of the lactation proteome
Because GO analysis suggested that components of the
traditional secretory pathway are up-regulated prior to
parturition, the potential mammary secretome was next
explored. The Pregnancy, Lactation, and Involution Gene
Sets were converted to mouse Swissprot IDs, which were
used to query LOCATE, a mouse database of cellular local-
ization data [18]. The cellular localization of the up-regu-
lated and down-regulated genes across each
developmental stage is tallied in Figures 6A and 6B,
respectively.
Interestingly, more secreted proteins (transcripts with sig-
nal peptides) are down-regulated during pregnancy and
lactation than are up-regulated. In fact, fewer than 100
transcripts with signal peptides are up-regulated during
pregnancy or lactation. This suggests that the secreted pro-
teins are limited to those important to milk compositionBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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and that other secretory functions are suppressed as the
gland single mindedly pursues its lactational course. Thus,
it is quite possible that the secretory pathway components
serve primarily to synthesize and secrete large volumes of
only a few proteins.
The caseins are high-abundance proteins synthesized in
the mammary gland. Rudolph et al. [3] studied the expres-
sion profiles of seventeen major milk protein genes: alpha-
casein  [GenBank:M36780],  beta-casein  [Gen-
Bank:X04490], gamma-casein [GenBank:D10215], kappa-
casein [GenBank:M10114], milk fat globule membrane pro-
tein E8 [GenBank:M38337], extracellular proteinase inhibi-
tor  [GenBank:X93037],  adipose differentiation related
protein  [GenBank:M93275],  whey acidic protein [Gen-
Bank:V00856], alpha-lactalbumin [GenBank:M87863], bile
salt stimulated lipase [GenBank:U37386],  lactotransferrin
[GenBank:J03298],  butyrophilin  [GenBank:U67065],
mucin 1 [GenBank:M84683], xanthine dehydrogenase [Gen-
Bank:X75129], casein delta [GenBank:V00740], epidermal
growth factor [GenBank:V00741], and parathyroid hormone-
like peptide [GenBank:M60057]. Principal component
analysis of these major milk proteins demonstrates that,
as a class, these genes are up-regulated sharply near the
time of parturition (Figure 7). All seventeen of these genes
are among the up-regulated genes in the Pregnancy Gene
Set, but only three of them are part of the Lactation Gene
Set. Thus, both the statistical analysis and principal com-
ponent analysis confirm that transcription of the major
milk proteins has reached steady state by the onset of lac-
tation.
Downstream components of the integrin pathway are broadly suppressed during lactation Figure 4
Downstream components of the integrin pathway are broadly suppressed during lactation. The integrin pathway 
is enriched with genes differentially regulated during (A) pregnancy, (B) lactation, and (C) involution. Green nodes are down-
regulated, red nodes are up-regulated.
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Protein interactions of genes expressed in the mammary 
gland
To characterize the interactions of proteins encoded by
genes transcribed during mammary development, protein
interaction networks were developed using the Pregnancy,
Lactation, and Involution Gene Sets. Up-regulated genes
from the three gene sets were converted from mouse
Affymetrix probe identifiers to human UniProt/Swissprot
Accessions and used to query the Online Predicted
Human Interaction Database (OPHID) [19]. Custom
scripts were written to create two types of networks for
each gene set: (1) networks that contain only interactions
of gene products with other gene products in the set
('within-set protein interactions' in Figure 8), and (2) net-
works that contain all known protein interactions with
gene products in the set ('all protein interactions' in Figure
8). Each node in the networks represents a protein and
each link between nodes represents a known protein-pro-
tein interaction from OPHID. Three-dimensional anima-
tions of these networks with labeled nodes and
spreadsheets detailing all of the linkages are available in
Additional data files 10, 11, 12, 13, 14, 15, 16.
Networks with few highly-connected nodes of high degree
(i.e., with many links) and with most nodes of low degree
(i.e., with few links) are considered to be scale-free. The
networks in Figure 8A, C, and 8D–F all have degree distri-
butions with similar shapes that appear to follow a power
law, as would be expected of scale-free biological net-
Protein ubiquitination is the most significantly regulated pathway during both lactation and involution Figure 5
Protein ubiquitination is the most significantly regulated pathway during both lactation and involution. The pro-
tein ubiquitination pathway is not significantly enriched with differentially regulated genes during (A) pregnancy. However, it is 
the most significantly enriched pathway during (B) lactation, and (C) involution. Green nodes are down-regulated, red nodes 
are up-regulated.
B
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works (data not shown). The degree distribution of the
network in Figure 8B is, trivially, a single point.
From the network in Figure 8C, it is clear that genes up-
regulated during involution do directly interact with each
other at the protein level and are highly connected. Genes
up-regulated by late pregnancy interact with each other to
a limited extent (Figure 8A), either because there are fewer
protein-protein interactions or because the protein inter-
actions in which they are involved in mammary cells have
not been observed in the high-throughput biology exper-
iments used to derive protein interaction data. Few genes
are up-regulated during lactation, and here (Figure 8B)
there is no evidence that they directly interact with each
other at the protein level. Again, some protein interac-
tions may occur that are unique to mammary cells and
would therefore not be present in these networks derived
from OPHID.
The star patterns in Figure 8E suggest that a couple of the
genes up-regulated during lactation directly interact with
many other proteins. Network analysis indicates that
these four lactation proteins are the most highly con-
nected: KH domain-containing, RNA-binding, signal
transduction-associated protein 1 (SAM68, [PIR:Q0766
6]), guanine nucleotide-binding protein subunit beta 4
(GBB4, [PIR:Q9HAV0]), C-jun-amino-terminal kinase-
interacting protein 1 (JIP1, [PIR:Q9UQF2]), and insulin-
like growth factor IB precursor (IGF1B, [PIR:P05019]).
SAM68, GBB4, JIP1, and IGF1B interact with 35, 16, 12,
and 11 proteins, respectively. Annotations in the UniProt
database [20] provide possible functions for these pro-
teins. SAM68 is an RNA binding protein that is involved
in mRNA processing. GBB4 is a G protein likely involved
as a modulator or transducer in various trans-membrane
signaling systems. JIP1 may function as a regulator of ves-
icle transport, through interactions with the JNK-signaling
components and motor proteins or as an anti-apoptotic
protein. IGF1B is an insulin-like growth factor. In sum-
mary, the networks in Figure 8 suggest that the extent of
Genes transcribed to form milk proteins are up-regulated  sharply near parturition and sustained through involution Figure 7
Genes transcribed to form milk proteins are up-regu-
lated sharply near parturition and sustained through 
involution. Principal component analysis was applied to the 
major milk proteins (see text). The first principal component 
depicted here explains 54.8% of the variance.
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Cellular localization data suggests a minority of secreted gene  products during pregnancy and lactation Figure 6
Cellular localization data suggests a minority of 
secreted gene products during pregnancy and lacta-
tion. Differentially transcribed genes are sorted by cellular 
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ucts. These proteins have no transmembrane domain or sig-
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interactions between proteins that are transcriptionally
regulated may be a function of reproductive stage, with
very few interactions occurring during lactation.
Development of a lactation protein interaction network
To develop a more comprehensive lactation protein-pro-
tein interaction network, the scientific literature was
mined for genes involved in lactation. Three gene sets –
the Literature Gene Set (see Methods), up-regulated genes
from the Pregnancy Gene Set, and up-regulated genes
from the Lactation Gene Set – were combined and used to
query the protein interaction database. Restricting the net-
work only to interactions between proteins in the query
list, this network contains 313 nodes and 438 linkages.
Approximately 71% of the nodes belong to a single major
component (subnetwork). The remaining nodes are asso-
ciated with subnetworks consisting of 6 or fewer nodes
each.
Viewing the major component (Figure 9), one can visual-
ize interesting targets that are not already described in the
literature. A three-dimensional animation of this network
Protein interaction networks represent differing post-transcriptional programs as a function of reproductive stage Figure 8
Protein interaction networks represent differing post-transcriptional programs as a function of reproductive 
stage. (A-C) In each network, nodes represent proteins whose genes are up-regulated in the (A) Pregnancy, (B) Lactation, and 
(C) Involution Gene Sets, while (A-C) links represent interactions with other proteins in the set. (D-F) In these networks, 
nodes represent either a protein whose gene is up-regulated in the (D) Pregnancy, (E) Lactation, or (F) Involution Gene Set, or 
(D-F) another protein not in the set that directly interacts with a protein in the set. (D-F) Links represent interactions between 
proteins in the set with each other or with other proteins not in the set. (A-F) All network figures were produced using the 
Fructerman-Reingold 3D layout algorithm. Three-dimensional animations of each network with labeled nodes are provided in 
Additional data files 11, 12, 13, 14, 15, 16. Spreadsheets of each protein-protein interaction are provided in Additional data file 
10.
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is available in Additional data file 18 with links described
in Additional data file 17. Circles in Figure 9 represent
those genes not in the lactation literature. Green circles are
up-regulated by late pregnancy and orange circles are up-
regulated by full lactation. Of the three transcripts up-reg-
ulated during full lactation that have not been previously
described in the lactation literature, two of the proteins –
D site-binding protein (DBP, [PIR:Q10586]) and thyro-
troph embryonic factor (TEF, [PIR:Q10587]) – are tran-
scription factors known to be related to circadian rhythms
and the third, SAM68 [PIR:Q07666], is a mediator of RNA
translation.
To understand what known functions are associated with
this comprehensive lactation network, GO analysis was
applied to the proteins in this network relative to all
human UniProt/SwissProt Accessions available through
Ensembl [21]. The top three non-synonymous GO terms
enriched in the lactation network (p < 0.001) are 'JAK-
STAT cascade,' 'anti-apoptosis,' and 'COPI coated vesicle
Protein interactions during lactation are visualized in this major component of the comprehensive lactation network Figure 9
Protein interactions during lactation are visualized in this major component of the comprehensive lactation 
network. This network provides a visualization of putative protein interactions between genes known and not previously 
known to be involved in lactation and those that are and are not transcriptionally regulated. Nodes in this network are mem-
bers of the Literature Gene Set or up-regulated members of the Pregnancy or Lactation Gene Sets that have protein interac-
tions in OPHID with other members of these sets. Node shape indicates whether or not the gene product is represented in 
the lactation literature. Square-shaped nodes are gene products from the Literature Gene Set. Circle-shaped nodes are up-reg-
ulated gene products either the Pregnancy or Lactation Gene Set that are not in the Literature Gene Set. Node color indicates 
whether the gene product is up-regulated during pregnancy (green), or lactation (orange), or neither (white). Links between 
nodes represent protein-protein interactions listed in OPHID. A three-dimensional animation of this network with labeled 
nodes is provided in Additional data file 18; each protein interaction is detailed in Additional data file 17.
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membrane'. All might have been predicted from previous
understanding of genes regulated during lactation.
Pathway analysis was also applied to the proteins in this
lactation network. The pathways most significantly
enriched (p < 0.005) with these proteins are the 'neuregu-
lin', 'JAK/Stat', 'NF-kappaB', 'PI3K/AKT', 'IL-4', 'PTEN',
and 'IGF-1' signaling pathways. In total, 38 pathways are
marginally statistically enriched (unadjusted p < 0.05), 22
of which are significantly enriched (p < 0.05). However,
no more than 20% of any one of these significant path-
ways is represented by nodes from the lactation network.
These facts together suggest that proteins in this network
are interacting in a way that is not well-characterized by
any individual canonical signaling or metabolic pathways
of this set of 152 curated pathways.
Hubs of a network are those nodes that are most highly
connected. The hubs of the lactation network are listed in
Table 5, ranked in order of connectivity. Hubs of protein
interaction networks are the proteins most essential to the
overall function of the network and they tend to be evolu-
tionarily conserved [22]. In other words, small perturba-
tions of the concentration or activation of these proteins
can have large effects. The 27 hubs of this lactation net-
work include receptors (EGFR, GHR, INSR, NR3C1,
SMAD2), signaling proteins (JAK2, PTPN6, ERBB2,
SOCS1, SOCS3, IRS1), transcription factors (STAT5A,
STAT3, CEBPB), translation initiation factors (EIF4E,
EIF3S4), as well as proteins involved in metabolism
(OAT, CBS, SARS, PGD, HDLBP), vesicle formation
(ATP6V1E1, COPB2, SEC23B), DNA repair (BRCA1),
gene silencing (HAT1), and protein degradation (UFM1).
Additional data file 23 contains manually annotated gen-
eral and mammary-specific functions of these hubs. Many
of these hub proteins have functions described in the sci-
entific literature, but their annotations are either not
descriptive of their role in mammary development or
their function has not been evaluated in the context of
mammary development. Unannotated hubs from the
table in additional data file 23, (CBS, ATP6V1E1, PGD,
HDLBP, COPB2, PTPN6, SARS, SEC23B, HAT1, UFM1,
and EIF3S4), are prime candidates for future exploration.
Discussion
The lactome
The identification of all genes responsible for lactation
was previously proposed [23]. However, the lactome is
spatially and temporally complex. For successful lactation
to occur, molecular events outside of the mammary gland
would be expected to support maternal-offspring behav-
iors, offspring sucking and rooting reflexes, offspring
Table 5: Major hubs of the comprehensive lactation network
No. of Links UniProt Accession/HGNC Symbol Protein Name
21 [PIR:P00533]/EGFR Epidermal growth factor receptor precursor
17 [PIR:P04181]/OAT Ornithine aminotransferase, mitochondrial
14 [PIR:P35520]/CBS Cystathionine beta-synthase
13 [PIR:O60674]/JAK2 Tyrosine-protein kinase JAK2
12 [PIR:P04626]/ERBB2 Receptor tyrosine-protein kinase erbB-2 precursor
12 [PIR:P40763]/STAT3 Signal transducer and activator of transcription 3
12 [PIR:P36543]/ATP6V1E1 Vacuolar ATP synthase subunit E
11 [PIR:P38398]/BRCA1 Breast cancer type 1 susceptibility protein
11 [PIR:P42229]/STAT5A Signal transducer and activator of transcription 5A
11 [PIR:P52209]/PGD 6-phosphogluconate dehydrogenase, decarboxylating
11 [PIR:Q00341]/HDLBP Vigilin
11 [PIR:P35606]/COPB2 Coatomer subunit beta
10 [PIR:P10912]/GHR Growth hormone receptor precursor
10 [PIR:P29350]/PTPN6 Tyrosine-protein phosphatase non-receptor type 6
10 [PIR:P06730]/EIF4E Eukaryotic translation initiation factor 4E
10 [PIR:P49591]/SARS Seryl-tRNA synthetase, cytoplasmic
10 [PIR:Q15437]/SEC23B Protein transport protein Sec23B
10 [PIR:O14929]/HAT1 Histone acetyltransferase type B catalytic subunit
9 [PIR:O14543]/SOCS3 Suppressor of cytokine signaling 3
9 [PIR:P35568]/IRS1 Insulin receptor substrate 1
9 [PIR:O15524]/SOCS1 Suppressor of cytokine signaling 1
9 [PIR:Q15796]/SMAD2 Mothers against decapentaplegic homolog 2
9 [PIR:P61960]/UFM1 Ubiquitin-fold modifier 1 precursor
8 [PIR:P06213]/INSR Insulin receptor precursor
8 [PIR:O75821]/EIF3S4 Eukaryotic translation initiation factor 3 subunit 4
8 [PIR:P17676]/CEBPB CCAAT/enhancer-binding protein beta
8 [PIR:P04150]/NR3C1 Glucocorticoid receptorBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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digestive response to the milk, and so forth. If one limits
the spatial scope to the mammary gland, this study dem-
onstrates temporal complexity as well. Even with a very
strict Bonferonni multiple testing correction (p < 0.001),
nearly a third of the mouse transcriptome is in flux from
pregnancy through involution. It is possible that some of
these changes are due to the expansion and contraction of
the epithelial compartment and concurrent proportional
representation of the stromal cells. Ultimately, house-
keeping genes of these changing cell populations may
need to be separated from genes that are uniquely regu-
lated in the context of the lactation apparatus. Despite
these obvious limitations, an initial list of genes that com-
prise the lactome – those differentially regulated by late
pregnancy relative to early pregnancy and by full lactation
relative to late pregnancy – are provided with this study
(see Pregnancy and Lactation Gene Sets in Methods).
Annotation of the lactome
Gene ontology annotations are not necessarily applicable
to the lactome as these annotations have arisen from stud-
ies in culture cells of other tissues. Here, the use of GO
annotations provides a method to screen for unexpected
biological functions (i.e., down-regulation of known ang-
iogenesis-related genes during pregnancy) and to identify
trends (i.e., reciprocal modulation of gene classes between
lactation and involution). Annotation with respect to the
specific biological context of lactation will ultimately be
required. The comprehensive lactation protein interaction
network derived in this paper provides a working model
for future work on molecular interactions in mammary
cells and highlights gene targets that have not yet been
annotated for lactation in the literature. Only 17% of the
regulated gene products in the network (Figure 9) co-
occur in the literature with the keyword, 'lactation'. Even
among the most central regulators – the hubs of the net-
work in Table 5 – eleven of the 27 (40.7%) do not yet have
a described role with respect to lactation or mammary
development.
The lactation switch
The transcriptional profiles of genes by functional class
(i.e., milk proteins, lipid synthesis, etc.) have been well-
described by a previous study [3], and the molecular
events surrounding secretory activation have been
recently reviewed [2]. This study illustrates, on a broader
perspective, very gradual transcriptional changes with
progression of reproductive stage until involution (Figure
2A). In other words, aside from small subsets of proteins
such as the major milk proteins, there is no sudden tran-
scriptional switch around the time of parturition. Prepara-
tions of the mammary gland for lactation include
modifications to the transcriptional program, but the
onset of lactation appears to be primarily controlled by
post-transcriptional mechanisms.
Regulation of proteins upstream of mRNA transcription
during lactation is not a new concept. In the presence of
lactogenic hormones, the mRNA of casein genes accumu-
lates rapidly due to increased RNA stability [24]. More
recently, enhancement of translation of the mRNA of the
beta-casein protein was found to occur by lengthening the
poly(A) tract via cytoplasmic polyadenylation synergized
by the activity of both prolactin and insulin signaling
[25]. The rate of translation has also been found to be
reduced by amino acid deprivation [26].
This study provides further targets for exploration of post-
transcriptional regulation in the mammary gland. Of the
mere 82 genes up-regulated during lactation relative to
late pregnancy, the gene with the most known interac-
tions at the protein level – the hub of the network with the
highest number of links – is SAM68, an RNA binding sig-
nal transduction protein. SAM68, also known as
KHDRBS1, is a putative regulator of mRNA splicing, trans-
lation, and nuclear export [27-29] and has recently been
shown to play a role in regulation of apoptotic genes [29].
SAM68, therefore, has the potential to be an important
post-transcriptional regulator of both milk secretion and
mammary cell survival during lactation. Other potential
post-transcriptional mediators of lactation exist among
the hubs of the comprehensive lactation network: the
eukaryotic translation initiation factors 4E (IF4E) and 3
subunit 4 (IF34). Long et al. hypothesized that IF4E may
effect translation of certain mRNA or the acceleration of
overall protein synthesis [30]. The existence of IF4E as a
hub in the lactation network certainly supports a central
regulatory role.
Network analysis in this study demonstrates that the pro-
teins encoded by genes transcriptionally up-regulated in
the mammary gland during lactation do not interact with
each other. Thus, regulation in MECs may substantially
occur through protein-protein interactions of gene prod-
ucts that pre-exist in the cell. To some extent, the differ-
ences seen in network connectivity, density, and shape
may be an artifact of gene set size. There are roughly twice
as many genes up-regulated during involution as there are
during pregnancy and more than ten times as many com-
pared to lactation. Also, because protein interaction data
is derived by high-throughput screens of protein interac-
tions in other cell systems, it is possible that unique pro-
tein interactions exist in the mammary gland have not yet
been observed.
Mammary epithelial cells during lactation
During lactation, MECs are essentially biofactories of lip-
ids, proteins, and carbohydrates for milk. The transcrip-
tional trends highlighted in this study imply that these
cells become biofactories not by gain of function, but by
a broad suppression of function to effectively push all ofBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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the cell's resources towards a very few important tasks
such as the massive synthesis of lipids and of a large quan-
tity of a minority of proteins. During lactation, MECs are
highly specialized, inhabiting an extreme transcriptional
state space that is the most divergent from the early preg-
nant state. The near-universal attenuation of integrin sig-
naling suggests that MECs isolate themselves from their
environment while they carry out their singular agenda.
The striking suppression of the proteolytic machinery in
both the GO and pathway analysis, particularly the ubiq-
uitination pathway, suggests that an early step in mam-
mary evolution was the acquisition of tolerance for such
quantities of protein structures beyond that normally
acceptable within cells. Such a suppression of proteolysis
may have been necessary to allow the emergence of nutri-
tionally functional proteins, particularly those with little
stabilizing secondary and tertiary structure. MECs during
lactation are truly unique and could serve as useful model
for biological questions that transcend mammary biol-
ogy.
Secretory diminution
Secretory diminution is the gradual decline in milk pro-
duction after peak lactation has been attained. The fact
that the machinery for milk synthesis appears to be in
place by the time of late pregnancy lends evidence
towards a new theory of secretory diminution. With the
genes contributing to the machinery down-regulated dur-
ing lactation, the machinery is not replenished as it
degrades over time. Thus, secretory diminution is neither
programmed nor pathological as recently reviewed [31];
rather, it is an inevitable feature of this biological design.
The involution switch
Using microarray technology, transcriptional profiles dur-
ing involution have been studied by numerous groups
[7,8,32,33]. Here, analysis of the transcriptome more
clearly demonstrates that a massive transcriptional switch
occurs between lactation and early involution (Figure 2A).
Five times as many transcripts are differentially regulated
at weaning relative to other times in the development of
the gland from the onset of the pregnancy. Conceptually,
a genome-wide transcriptionally-driven switch at involu-
tion may be biologically necessary because the timing of
weaning is determined by the offspring and therefore, is
unpredictable. Thus, the mammary gland cannot make
gradual preparations for its onset. The signals responsible
for this event are likely to be of interest for many biologi-
cal processes particularly related to tissue remodeling.
The analysis in this study implies that transcriptional
changes during early involution may function, in part, to
revert the mammary gland to the pre-lactation state. First,
the state space of the transcriptome gradually diverges
from the onset of pregnancy through lactation and then,
at involution, the transcriptome partially converges to the
pre-lactation state (Figure 2B). More than half of the tran-
scriptional changes during the transition from lactation to
early involution bring the gland back to the transcrip-
tional state of late-pregnancy. Second, GO analysis dem-
onstrated that functionally, the transcriptional state is
largely a reversion to the pre-lactation state – 85% of the
enriched GO terms associated with up-regulation during
involution exactly match GO terms of the genes down-
regulated during lactation. To study involution, prior syn-
theses of microarray data have been applied exclusively to
involution time points [34]. However, comparison of
these involution time points to transcriptional changes
during pregnancy should improve the ability to sort the
many signals that are multiplexed during this very com-
plex time period.
The transcriptional state space of a full lactation cycle was
previously explored by Master et al using a three-dimen-
sional visualization of the dimensionality-reduced pair-
wise distances between developmental time points [7].
The observation in this study that the state space of the
transcriptome gradually diverges from the onset of preg-
nancy through lactation is consistent with their model.
However, the observed partial convergence of the early
involution transcriptional state towards the pre-lactation
state is not suggested by their visualization. There are a
couple of possibilities for this discrepancy. It is possible
that the early involution time point is much closer to the
near-parturition time point in their model than appears
on the page in two dimensions. Second, the shape of the
entire trajectory may be overly constrained in low dimen-
sions such that the goodness-of-fit between any two of the
developmental time points is compromised. In this study,
for the particular question of whether the early involution
transcriptional state is a partial reconvergence to the pre-
lactation state, the pairwise differences are directly meas-
ured so the observed distances are unequivocal.
The network of interactions between proteins that are
encoded from genes up-regulated during early involution
is well-connected. This suggests that the process of early
involution is coordinately regulated. That is, genes up-reg-
ulated together produce proteins that interact with each
other. Furthermore, the cellular processes are unlikely to
be unique to involution of the mammary gland because
they are described by protein interaction data derived
from other cell cultures. The protein interaction network
at the time of involution (Additional data file 16) pro-
vides a roadmap for future molecular studies of involu-
tion.
The milk proteome
GO analysis in this study suggests that much of the
machinery for the secretory pathway is transcribed priorBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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to lactation. Because very few genes are up-regulated dur-
ing lactation relative to late pregnancy, this secretory path-
way is likely devoted to the secretion of large amounts of
a few proteins. Highly expressed milk protein genes, such
as the caseins, account for as much as 30% of total RNA
(personal communication, MC Neville). As a group, genes
transcribed to form these major milk proteins are up-reg-
ulated sharply around the time of parturition.
Assessments of the number of unique proteins in the milk
proteome differ due to technical limitations in available
proteomic technologies. In this study, fewer than 100
genes whose proteins are destined for secretion were up-
regulated during either pregnancy or lactation. This sug-
gests that the endogenous portion of the milk proteome
that is synthesized through the secretory pathway is
derived from fewer than 100 transcripts. Some proteins
such as immunoglobins, transferrin, and albumin enter
the milk by the transcytosis pathway [35-37]. Thus, if the
diversity of the milk proteome proves to be substantially
greater than 100 proteins, that diversity is due to either to
post-translational modifications of these 100 transcripts
or to the import by the gland of many more exogeneous
proteins than previously realized.
The small number of up-regulated transcripts with signal
peptides also suggests that secretory functions not related
to lactation are turned off while only those important to
milk composition are retained. This biological principle is
consistent with the view that the MECs have reached a
very specialized transcriptional state that is single mind-
edly devoted to milk secretion.
Implications for cancer research
During pregnancy, lactation, and involution, nearly a
third of the mouse transcriptome is in flux within the
mammary gland during which the proliferation, differen-
tiation, and death of cells are exquisitely controlled. The
survival of mammalian species depends on the ability of
these cells to traverse this vast transcriptional state space
repeatedly without malignancy. As such, normal mam-
mary development provides a rich model system for the
study of cellular development and the effects of perturba-
tion.
Intriguingly, GO analysis revealed that genes known to be
involved in angiogenesis in other tissues are, as a class,
down-regulated during pregnancy. On a macroscopic
level, the vascularization of the gland clearly increases. In
the rat, the vasculature doubles by mid-pregnancy [10].
The 'angiogenesis' GO annotations are likely dictated by
cancer research, so there may be genes that are important
to angiogenesis in normal mammary development that
are not yet annotated as such. Angiogenesis within the
normal developing mammary gland may fundamentally
differ from that of the neoplastic transformation. Other
evidence of this hypothesis is provided by HIF1alpha. In
human tumors, HIF1alpha was up-regulated, particularly
in breast tumors that exhibit high rates of prolifera-
tion[38,39]. However, in the HIF1alpha null mouse
mammary gland, vasculature development was
unchanged [40]. Taken together, these studies imply that
the angiogenesis of breast cancer is not merely the
untimely enabling of the normal mammary vasculariza-
tion circuit.
Limitations
The techniques and data used in this study have several
limitations worth noting. First, principal component
analysis reduces the dimensionality of a data set by retain-
ing components of the data that contribute most to its var-
iance. These lower order components are generally the
most important; however, it is possible that these compo-
nents are unimportant or that the discarded higher order
components are biologically relevant. Second, the appli-
cation of GO analysis is unlikely to completely describe
the function of genes transcribed during mammary devel-
opment as many genes have not yet been annotated in
this biologically unusual context. Third, the statistical
tests commonly available to assess the significance of
enrichment in the GO and pathway analyses are anti-con-
servative and based on flawed assumptions [41]. A multi-
ple testing correction was used to mitigate the former, but
solutions for the latter are not readily available. Also,
enrichment of small gene sets, such as the set of genes that
form products of the JAK-Stat pathway, are overly sensi-
tive to small perturbations in the gene set under test, a
property that will be inherent to any statistical test of
enrichment. Fourth, the network analysis in this study is
limited by the integrity of the underlying data. Protein
interaction data, derived largely from large-scale yeast
two-hybrid experiments, is known to contain both false
positives and missed interactions [42]. It is also highly
likely that protein interactions important to mammary
development are incompletely represented by experi-
ments with other cell types. Lastly, the microarray chips
utilized were limited to 12,488 probes so it is possible that
some differentially regulated transcripts were not meas-
ured.
Conclusion
Bioinformatic techniques were applied to various data
sets to derive global biological principles governing the
molecular events in the mammary gland during preg-
nancy, lactation, and involution. The key biological prin-
ciples identified include the following: (1) nearly a third
of the transcriptome fluctuates to build, run, and disas-
semble the lactation apparatus; (2) genes encoding the
secretory machinery are transcribed prior to lactation; (3)
the diversity of the endogenous portion of the milk pro-BMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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teome is derived from fewer than 100 transcripts; (4)
while some genes are differentially transcribed near the
onset of lactation, the lactation switch is primarily post-
transcriptionally mediated; (5) the secretion of materials
during lactation occurs not by up-regulation of novel
genomic functions, but by widespread transcriptional
suppression of functions such as protein degradation and
cell-environment communication; (6) the involution
switch is primarily transcriptionally mediated; and (7)
during early involution, the transcriptional state is par-
tially reverted to the pre-lactation state. These guiding
principles begin to establish a road map for future study
of mammary development during pregnancy, lactation,
and involution.
The seeds for new hypotheses are also provided in this
study. First, secretory diminution, usually attributed to
programmed cell death or oxidative damage, may actually
be due to lack of replenishment of the secretory machin-
ery at the mRNA level. GO analysis in this analysis sug-
gests that once lactation has commenced, transcription of
RNA to maintain the secretory machinery is not sustained.
It is, therefore, inevitable that milk production will gradu-
ally decrease over time. Second, angiogenesis-related
genes are down-regulated during pregnancy, while vascu-
lature in the gland clearly increases. This suggests that the
angiogenesis of breast cancer is fundamentally pathologi-
cal, rather than an inappropriate launch of normal vascu-
larization processes.
In addition to the biological principles derived in this
paper, extensive supplementary materials are provided as
a mineable resource for mammary biologists. The 22
additional data files include sets of differentially
expressed genes, associated GO terms, libraries of anno-
tated pathway diagrams, and developmental stage-specific
protein interaction networks. The comprehensive lacta-
tion network of protein interactions assembled in this
study prioritizes regulatory gene targets for future study
and provides a framework from which to base future
research. The network enables the visualization of connec-
tivity between those gene products known to be involved
in lactation and those previously unexplored in the lacta-
tion literature. These integrative methods can be applied
to other areas of biological inquiry to establish a snapshot
of current knowledge and to facilitate the generation of
new hypotheses.
Methods
Microarray study design
This microarray study was previously described in
Rudolph et al. [3]. Briefly, mammary gland RNA samples
were collected from FVB mice, isolated, and hybridized
onto Affymetrix MG_U74Av2 chips. In total, ten time
points in mammary development with four biological
replicates for each time point were produced: P1, the day
a vaginal plug was observed; P3, pregnancy day 3; P7,
pregnancy day 7; P12, pregnancy day 12; P17, pregnancy
day 17; P19, pregnancy day 19; L1, early lactation, the first
day pups are observed in the cage, L2, lactation day 2; L9,
lactation day 9; and I2, two days after pup removal on lac-
tation day 9. Histologically, the mammary proliferative
stage is represented by P1, P3, and P7, the secretory differ-
entiation stage by P12, P17, and P19, early lactation by L1
and L2, full lactation by L9, and involution by I2. These
data have been deposited in NCBI's Gene Expression
Omnibus [43] and are accessible through GEO Series
accession number GSE8191.
Microarray data analysis
GeneSpring GX 7.3.1 was used to analyze the data. First,
GC-RMA preprocessing was applied to all CEL files. Signal
intensity values were normalized as follows. Values below
0.01 were set to 0.01. Each measurement was divided by
the 50.0th percentile of all measurements in that sample.
Each gene was divided by the median of its measurements
in all samples. If the median of the raw values was below
10, then each measurement for that gene was divided by
10 if the numerator was above 10, otherwise the measure-
ment was discarded.
The 12,488 genes were then pre-filtered to remove those
genes with unreliable or undetectable signals. Those that
did not have an Affymetrix call of 'Present' in at least four
of the forty samples were discarded. Additionally, genes
with consistently low expressing signal across all ten
developmental stages were removed using a minimum
threshold of 0.712, empirically decided using Gene-
Spring's Cross Gene Error Model. Genes that did not
exceed this threshold in at least one of the ten develop-
mental stages were removed. The remaining 7,534 genes
were used for subsequent analysis.
To find genes that were significantly differentially
expressed during different developmental stages of the
mammary gland, from initial pregnancy to involution, a
one-way ANOVA was applied with a Bonferroni multiple
testing correction, p-value cutoff of 0.001. No genes
would be expected to pass this restriction by chance.
4,832 genes passed. To find genes significantly differen-
tially expressed between individual development stages,
all pairwise comparisons were examined with a Tukey
post hoc test (p < 0.001).
Pregnancy, lactation, and involution gene sets
The Pregnancy Gene Set, listed in Additional data file 3, is
the cluster of genes that are significantly differentially reg-
ulated between the start of pregnancy (time point P1) and
late pregnancy (time point P19). The Lactation Gene Set,
Additional data file 4, is the group of genes significantlyBMC Systems Biology 2007, 1:56 http://www.biomedcentral.com/1752-0509/1/56
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differentially regulated between late pregnancy (time
point P19) and full lactation (time point L9). The Involu-
tion Gene Set, Additional data file 5, refers to those genes
significantly differentially regulated between full lactation
(time point L9) and involution (time point I2). The Tukey
post hoc test was applied to all pairwise comparisons to
determine significance (p < 0.001).
Literature Gene Set
The Single Gene Biological Term Mapper feature of
CoPub Mapper [44] was used to extract all of the genes co-
occuring in PubMed publications with the biological
process keyword 'lactation'. In total, 685 genes have been
co-published with 'lactation' two or more times. Of these
genes, 456 co-occur with a relative score greater than zero.
The relative score, previously described [44], is a measure
of the frequency of co-occurrence adjusted for the fre-
quency of occurrence of each item individually. This set of
456 genes – those genes known to be involved in lactation
– comprise the Literature Gene Set, provided in Addi-
tional data file 6.
Gene ontology analysis
MAPPFinder 2.0 within GenMAPP 2.0 [45] was used to
identify gene ontology (GO) terms that are over-repre-
sented by significantly regulated genes compared to the
full genome-wide set of Affymetrix ProbeIDs given the
most recent mouse gene database, Mm-Std_20060628.g
db. Custom Perl and shell scripts were written to format
the data for analysis. To determine statistical significance,
a Benjamini and Hochberg multiple testing correction
was applied to GenMAPP's permuted p values with a cus-
tom R script using the multtest library [46,47]. In each
analysis, statistically enriched GO terms are those terms
with 3 or more associated genes, a positive z-score, and a
Benjamini and Hochberg adjusted p-value less than or
equal to 0.05. Thus, a False Discovery Rate of 5% or less
would be expected for these enriched GO terms. These
same statistical tests were applied to determine enriched
GO terms among genes correlated with the principal com-
ponents and among gene products represented in the lac-
tation network.
Pathway analysis
Ingenuity Pathways Analysis [48] was used to identify
metabolic and signaling pathways that are over-repre-
sented by significantly regulated genes compared to all of
the genes that are part of the Ingenuity Pathways Knowl-
edge Base. The Ingenuity Pathways Analysis library of
canonical pathways includes 80 metabolic and 72 signal-
ing pathways that have been incorporated from various
resources and hand-curated. Genes that were statistically
up-regulated or down-regulated between the time points
studied (i.e. P1 to P19, P19 to Lac9, Lac9 to Inv2) and
were associated with a canonical pathway were considered
for the analysis. A Fischer's exact test was used to calculate
a p-value to determine the probability that the enrich-
ment of the canonical pathway with these genes is
explained by chance alone. In this paper, this p-value is
referred to as the unadjusted p-value. To improve the
stringency of the test, a Benjamini and Hochberg multiple
testing correction was applied to the unadjusted p values
with a custom R script using the multtest library [46,47].
Unless otherwise stated, pathways reported to be statisti-
cally significant are those with a Benjamini and Hochberg
adjusted p-value less than or equal to 0.05. These same sta-
tistical tests were applied to determine enriched pathways
among genes correlated with the principal components
and among gene products represented in the lactation net-
work.
Protein interaction network analysis
Gene lists were converted to Human Swissprot IDs using
tables from the Ensembl database, release 41 [21]. For
each list of Human Swissprot IDs, interactions between
those gene products were obtained from OPHID [19] and
post-processed using custom scripts to determine all of
the linkages in the network and to generate a network file.
This network file was then explored using Pajek 1.16 [49],
a program for large network analysis.
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Additional material
Additional file 1
Additional data file 1 is an Excel spreadsheet that lists genes with a stand-
ard correlation of 0.90 or better with the first principal component.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S1.xls]
Additional file 2
Additional data file 2 is an Excel spreadsheet that lists genes that are sup-
pressed during lactation. These genes are down-regulated by L2 relative to 
P17 and up-regulated by I2 relative to L9.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S2.xls]
Additional file 3
Additional data file 3 is an Excel file that lists genes that are members of 
the Pregnancy Gene Set. These genes are differentially regulated between 
time points P1 and P19. Two spreadsheets are provided in the file, one for 
up-regulated and one for down-regulated genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S3.xls]
Additional file 4
Additional data file 4 is an Excel file that lists genes that are members of 
the Lactation Gene Set. These genes are differentially regulated between 
time points P19 and L9. Two spreadsheets are provided in the file, one for 
up-regulated and one for down-regulated genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S4.xls]
Additional file 5
Additional data file 5 is an Excel file that lists genes that are members of 
the Involution Gene Set. These genes are differentially regulated between 
time points L9 and I2. Two spreadsheets are provided in the file, one for 
up-regulated and one for down-regulated genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S5.xls]
Additional file 6
Additional data file 6 is an Excel file that lists genes that are members of 
the Literature Gene Set. These genes have been co-published with the key-
word 'lactation'.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S6.xls]
Additional file 7
Additional data file 7 is an Excel file of genes that are associated with the 
GO terms in Table 2 and are members of the Pregnancy Gene Set (i.e. 
differentially regulated between time points P1 and P19). Two spread-
sheets are provided in the file, one for up-regulated and one for down-reg-
ulated genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S7.xls]
Additional file 8
Additional data file 8 is an Excel file of genes that are associated with the 
GO terms in Table 3 and are members of the Lactation Gene Set (i.e. dif-
ferentially regulated between time points P19 and L9). Two spreadsheets 
are provided in the file, one for up-regulated and one for down-regulated 
genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S8.xls]
Additional file 9
Additional data file 9 is an Excel file of genes that are associated with the 
GO terms in Table 4 and are members of the Involution Gene Set (i.e. 
differentially regulated between time points L9 and I2). Two spreadsheets 
are provided in the file, one for up-regulated and one for down-regulated 
genes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S9.xls]
Additional file 10
Additional data file 10 is an Excel file that provides HGNC symbols, 
Swissprot identifiers, and descriptions for each protein interaction pair 
associated with Figure 8. Six spreadsheets are provided in the file, one for 
each of the networks in Figure 8.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S10.xls]
Additional file 11
Additional data file 11, an SWF movie file, is a 3D animation of the net-
work in Figure 8A (the within-set pregnancy network) in which the nodes 
are labeled with HGNC symbols. The HGNC symbols, Swissprot identifi-
ers, and descriptions for each protein interaction pair are given in Addi-
tional file 10.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
0509-1-56-S11.swf]
Additional file 12
Additional data file 12, an SWF movie file, is a 3D animation of the triv-
ial network in Figure 8B (the within-set lactation network) in which the 
nodes are labeled with HGNC symbols. The HGNC symbols, Swissprot 
identifiers, and descriptions for each protein interaction pair are given in 
Additional file 10.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1752-
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